ENGOT EN-9

About this trial

Patient Profile

Advanced or recurrent endometrial carcinoma

Where’s this trial being run?

Cork University Hospital and St James’s Hospital

Can I join this study / trial?

The first thing you do is to talk to your doctor and/or the cancer trials research team in your hospital. The contact details for the cancer trials research units in Ireland is here.

Why not Print this page and bring it with you. It will help your doctor and research team advise you.

For more detailed information

Questions?

Here’s a list of questions you may have for your doctor or local cancer research team.


Summary Data

Name: ENGOT EN-9
Number: CTRIAL-IE 19-20
Full Title:

A Phase 3 Randomized, Open Label Study of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK7902)Versus Chemotherapy for first line treatment of advanced or recurrent endometrial carcinoma

Principal Investigator: Dearbhaile O'Donnell
Type: Collaborative
Sponsor:

MSD

Recruitment Started: Global:
Ireland:
Global Recruitment Target: 720
Ireland Recruitment Target: TBC